Stella Pharma Recalls Cancer Radiation Therapy over Flawed Testing at Kyowa CritiCare

February 17, 2021
Stella Pharma said on February 15 that it has launched a voluntary recall for one lot of Steboronine 9000 mg/300 mL for infusion (borofalan ( 10 B)), an agent for boron neutron capture therapy (BNCT), due to flawed testing procedures...read more